Hudock, Inc. Adaptive Biotechnologies Corp Transaction History

Hudock, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$32.22 - $44.59 $28,998 - $40,131	-900 Closed	0 $0
Q3 2019 Oct 31, 2019	SELL	$30.31 - $53.51 $12,124 - $21,404	-400 Reduced 30.77%	900 $27,000
Q2 2019 Jul 30, 2019	BUY	$40.3 - $48.3 $52,389 - $62,789	1,300 New	1,300 $62,000

204

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $973M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Hudock, Inc., based on Form 13F filings with the SEC.

Stay updated on Hudock, Inc. with notifications on news.